StockData

Balchem vs Ingevity

BCPC and NGVT side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BCPC and NGVT compare

Balchem is the larger company, worth 2.6 times as much as Ingevity ($5.4B against $2.1B).

On earnings, Balchem is cheaper: it trades at 32.3× trailing earnings, against 40.8× for Ingevity.

Balchem grew revenue faster over the last twelve months (9.4% versus −1.4% for Ingevity).

Balchem keeps more of each dollar of sales as profit, with a net margin of 15.4% compared with 4.7% at Ingevity.

Balchem pays a dividend yielding 0.56%; Ingevity does not pay one.

Balchem scores higher on the StockData Score (19 against 6 for Ingevity), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBCPCNGVT
Size and price
Market cap$5.4B$2.1B
Share price$171.48$60.02
Change, 1 year9.2%18.8%
Change, 5 years3.8%−19.2%
Beta (5Y)0.120.75
Employees1,3521,500
StockData Score
Total score19 (better)6
Valuation score2 (better)0
Growth score4 (better)2
Performance score5 (better)3
Health score6 (better)1
Dividend score2 (better)0
Valuation
P/E32.3× (better)40.8×
P/S4.9×1.8× (better)
P/B4.1× (better)44.0×
EV/EBITDA19.3× (better)22.9×
P/FCF–13.3×
PEG2.39–
FCF yield–7.5%
Fair value$149.11$33.97
Margin of safety−15.0% (better)−76.7%
Growth
Revenue growth (TTM)9.4% (better)−1.4%
Revenue growth, 5Y average8.1% (better)−0.81%
Net income growth (TTM)14.5%–
EPS growth (TTM)16.2%–
EPS growth, 5Y average12.8%–
Profitability
Gross margin36.5%41.1% (better)
Operating margin20.7%–
Net margin15.4% (better)4.7%
FCF margin–13.4%
Return on equity13.0%64.4% (better)
Return on invested capital14.3%–
Financial health
Debt / equity0.0025.59 (better)
Net debt / EBITDA–7.97
Current ratio2.47 (better)1.61
Altman Z-score10.97 (better)2.20
Piotroski F-score9 (better)6
Dividends and buybacks
Dividend yield0.56%–
Payout ratio18.0%–
Years of dividend growth3–
Buyback yield2.3%6.9% (better)
Shareholder yield2.9%6.9% (better)
Ownership
Held by institutions91.3%102%
Held by insiders0.72%1.4%
Insider net buying, 12 months−$2.2M−$1.8M (better)
Short interest, % of float1.6%3.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.